You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T-cell

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Human Immunodeficiency Virus, Treatment, Antiretroviral Therapy Trial in Seattle (TLC-ART)

Recruiting
  • Human Immunodeficiency Virus
  • +2 more
  • Seattle, Washington
    UW Positve Research, Harborview Medical Center
May 8, 2023

Triple Negative Breast Tumors Trial (Xiaopi granules, Xiaopi decoction, Placebo)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • Xiaopi granules
  • +2 more
  • (no location specified)
Nov 22, 2023

NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Sugemalimab and Chemotherapy
  • Changsha, China
    Hunan Cancer Hospital
Jul 7, 2023

Diffuse Large B Cell Lymphoma Trial in Shanghai (Zanubrutinib, Polatuzumab vedotin and Rituximab)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Zanubrutinib, Polatuzumab vedotin and Rituximab
  • Shanghai, Shanghai, China
    Zhongshan Hospital，Fudan University
Jul 10, 2023

NSCLC (NSCLC) Trial (Osimertinib, Amivantamab)

Not yet recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • (no location specified)
Mar 24, 2023

Non Small Cell Lung Cancer Trial (Jinfukang oral liquid, Platinum-based doublet chemo)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Jinfukang oral liquid
  • Platinum-based doublet chemotherapy
  • (no location specified)
Oct 17, 2021

Shear-wave Elastography in Breast Cancer

Not yet recruiting
  • Breast Cancer
  • elastography
  • (no location specified)
Nov 3, 2023

HER2-positive Breast Cancer Trial in Nanjing (Pyrotinib)

Recruiting
  • HER2-positive Breast Cancer
  • Nanjing, Jiangsu, China
    JiangSu Province Hospital/ The First Affiliated Hospital of Nanj
Apr 26, 2023

Clear Cell Renal Cell Carcinoma Trial in Duarte, Nashville (XmAb819)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • XmAb819
  • Duarte, California
  • +1 more
Jun 20, 2022

Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell

Withdrawn
  • Multiple Indications Cancer
  • Non-Interventional
  • Mexico, Distrito Federal, Mexico
    Local Institution
May 25, 2022

NSCLC Trial in Worldwide (Osimertinib, Placebo)

Recruiting
  • Non-Small Cell Lung Cancer
  • Anchorage, Alaska
  • +168 more
Jan 9, 2023

Ataxia Telangiectasia Trial in Frankfurt (Lumbar puncture)

Completed
  • Ataxia Telangiectasia
  • Lumbar puncture
  • Frankfurt, Hessen, Germany
    Johann Wolfgang Goethe University Hospitals
Aug 30, 2021

Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

Recruiting
  • Lung Neoplasm
  • +26 more
  • Boston, Massachusetts
  • +6 more
Jun 23, 2022

Idiopathic Membranous Nephropathy Trial (Rituximab, Cyclophosphamide)

Not yet recruiting
  • Idiopathic Membranous Nephropathy
  • (no location specified)
Aug 22, 2022

The Clinical Manifestations of Severe Acute Respiratory

Completed
  • Covid19
    • Assiut, Egypt
      Assiut University Hospital
    Jun 5, 2022

    3D-MRE for Assessing Cirrhosis and Portal Hypertension

    Not yet recruiting
    • Cirrhosis, Liver
    • Portal Hypertension
    • 3D-MRE
    • HVPG
    • (no location specified)
    Jul 26, 2022

    Gastroscopy, Barrett's Esophagus Trial in Portsmouth

    Not yet recruiting
    • Gastroscopy
    • Barrett's Esophagus
      • Portsmouth, Hampshire, United Kingdom
        Queen Alexandra Hospital, Portsmouth Hospitals University NHS tr
      Jul 25, 2023

      Recurrent Breast Inflammatory Carcinoma, Stage IV Breast Inflammatory Carcinoma Trial in Houston (Atezolizumab, Cobimetinib,

      Recruiting
      • Recurrent Breast Inflammatory Carcinoma
      • Stage IV Breast Inflammatory Carcinoma
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 11, 2021

      BIOlogics in Severe Nasal POlyposis SurvEy

      Recruiting
      • Chronic Rhinosinusitis With Nasal Polyps
      • Biologic treatments available in CRSwNP (dupilumab, mepolizumab and benralizumab according to their marketing approval)
      • Lille, France
        Hop Claude Huriez Chu Lille
      Apr 4, 2022

      Traumatic Tap Trial in Montréal (Lumbar puncture using the stylet-in technique, Lumbar puncture using the stylet-out technique)

      Recruiting
      • Traumatic Tap
      • Lumbar puncture using the stylet-in technique
      • Lumbar puncture using the stylet-out technique
      • Montréal, Quebec, Canada
        CHU Sainte-Justine
      Aug 16, 2021

      HIV Trial (Cabotegravir IR Formulation (reference), Cabotegravir DT Formulation (test 1), Cabotegravir DT Formulation (test 2))

      Not yet recruiting
      • HIV Infections
      • Cabotegravir IR Formulation (reference)
      • +2 more
      • (no location specified)
      Mar 8, 2023

      Osimertinib for NSCLC With Uncommon EGFR Mutations

      Enrolling by invitation
      • Carcinoma, Non-Small-Cell Lung
      • Genes, erbB-1
      • Ramat Gan, Israel
        Sheba Medical Centre
      Jun 14, 2022

      MDS, Multiple Myeloma, Anemia Trial in France, Italy, United States (INCB000928)

      Recruiting
      • Myelodysplastic Syndromes
      • +2 more
      • Palo Alto, California
      • +13 more
      Dec 12, 2022

      COVID-19, Coronavirus Infections, Respiratory Tract Infections Trial in Russian Federation (Subunit recombinant vaccine for the

      Active, not recruiting
      • COVID-19
      • +3 more
      • Subunit recombinant vaccine for the prevention of coronavirus infection
      • Placebo
      • Moscow, Russian Federation
      • +5 more
      Feb 9, 2023

      MDS, Chronic Myelomonocytic Leukemia-2, Secondary Acute Myeloid Leukemia Trial in Nanjing (unrelated umbilical cord blood)

      Recruiting
      • Myelodysplastic Syndromes
      • +2 more
      • unrelated umbilical cord blood
      • Nanjing, Jiangsu, China
        The First Affiliated Hospital with Nanjing Medical University
      Oct 16, 2022